Recent Articles
Dip Your Toes in iBio Stock, but Remember That Viability Is Still an Issue
By
Larry Sullivan, InvestorPlace contributor
There's promise in IBIO stock but potential investors need to study the biotech company carefully before placing their bets.
Further Cruise Cancellations Make Case to Steer Clear of Carnival Stock
By
Larry Sullivan, InvestorPlace contributor
Covid-19 is crushing the travel industry, especially cruise operators. Now is not the time to buy shares of CCL stock.
![Louis Navellier's Market 360 logo](https://investorplace.com/wp-content/uploads/2021/10/lnel-logo-new-175x25-1.png)
Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.